Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 2
1980 1
1981 3
1982 5
1983 5
1984 3
1985 1
1986 7
1987 5
1988 8
1989 4
1990 6
1991 4
1992 4
1993 9
1994 12
1995 11
1996 16
1997 16
1998 11
1999 12
2000 14
2001 14
2002 6
2003 5
2004 7
2005 8
2006 11
2007 7
2008 6
2009 7
2010 4
2011 8
2012 4
2013 10
2014 5
2015 9
2016 4
2017 7
2018 3
2019 5
2020 3
2021 4
2022 6
2023 3
2024 3
2025 2
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

301 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Bismuth-based triple therapy with bismuth subcitrate, metronidazole and tetracycline in the eradication of Helicobacter pylori: a randomized, placebo controlled, double-blind study.
Veldhuyzen Van Zanten S, Farley A, Marcon N, Lahaie R, Archambault A, Hunt R, Bailey R, Owen D, Spénard J, Stiglick A, Aimola N, Colin P. Veldhuyzen Van Zanten S, et al. Can J Gastroenterol. 2000 Jul-Aug;14(7):599-602. doi: 10.1155/2000/690307. Can J Gastroenterol. 2000. PMID: 10978947 Clinical Trial.
OBJECTIVE: To determine the rate of Helicobacter pylori eradication following bismuth-based triple therapy with colloidal bismuth subcitrate, tetracycline hydrochloride and metronidazole. PATIENTS AND METHODS: One hundred and eleven patients were randomly assigned, …
OBJECTIVE: To determine the rate of Helicobacter pylori eradication following bismuth-based triple therapy with colloidal bismuth …
Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN, Hahm JS, Kim HJ. Park KN, et al. Eur J Gastroenterol Hepatol. 1994 Dec;6 Suppl 1:S103-7. Eur J Gastroenterol Hepatol. 1994. PMID: 7735924 Clinical Trial.
PURPOSE: Two 4-week triple-therapy treatment regimens, metronidazole+tetracycline+bismuth subcitrate and omeprazole+amoxycillin+bismuth subcitrate, were compared in a randomly allocated double-blind trial for their efficacy in eradicating Helicobacter …
PURPOSE: Two 4-week triple-therapy treatment regimens, metronidazole+tetracycline+bismuth subcitrate and omeprazole+amoxycilli …
Combination treatment: colloidal bismuth subcitrate with H2-antagonists.
Salmon PR. Salmon PR. Digestion. 1987;37 Suppl 2:42-6. doi: 10.1159/000199557. Digestion. 1987. PMID: 2887475 Clinical Trial.
A formal single-blind multicentre study has been set up to investigate the probable benefit of combined therapy of the cytoprotective agent De-Nol (colloidal bismuth subcitrate, CBS) and an acid-suppressing drug (cimetidine) in the treatment of duodenal ulcer. ...
A formal single-blind multicentre study has been set up to investigate the probable benefit of combined therapy of the cytoprotective agent …
Colloidal bismuth pectin: an alternative to bismuth subcitrate for the treatment of Helicobacter pylori--positive duodenal ulcer.
Nie Y, Li Y, Wu H, Sha W, Du H, Dai S, Wang H, Li Q. Nie Y, et al. Helicobacter. 1999 Jun;4(2):128-34. doi: 10.1046/j.1523-5378.1999.98281.x. Helicobacter. 1999. PMID: 10382127 Clinical Trial.
MATERIALS AND METHODS: In this prospective trial, 205 patients with H. pylori-positive duodenal ulcer were allocated randomly to receive one of four regimens: metronidazole, 200 mg; amoxicillin, 250 mg; and colloidal bismuth subcitrate (CBS), 120 mg (group 1), or CB …
MATERIALS AND METHODS: In this prospective trial, 205 patients with H. pylori-positive duodenal ulcer were allocated randomly to receive one …
One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
Kung NN, Sung JJ, Yuen NW, Li TH, Ng PW, Lai WM, Lui YH, Lam KN, Choi CH, Leung EM. Kung NN, et al. Am J Gastroenterol. 1999 Mar;94(3):721-4. doi: 10.1111/j.1572-0241.1999.00942.x. Am J Gastroenterol. 1999. PMID: 10086657 Clinical Trial.
METHODS: Patients with H. pylori-related ulcer disease or gastritis were randomized to receive either 400/mg of RBC twice daily plus 400/mg of metronidazole and 500/mg of tetracycline four times daily for 1 wk (RMT) or 120/mg of colloidal bismuth subcitrate, 400/mg …
METHODS: Patients with H. pylori-related ulcer disease or gastritis were randomized to receive either 400/mg of RBC twice daily plus 400/mg …
Double-blind comparison of absorbable colloidal bismuth subcitrate and nonabsorbable bismuth subnitrate in the eradication of Helicobacter pylori and the relief of nonulcer dyspepsia.
Whitehead MW, Phillips RH, Sieniawska CE, Delves HT, Seed PT, Thompson RP, Powell JJ. Whitehead MW, et al. Helicobacter. 2000 Sep;5(3):169-75. doi: 10.1046/j.1523-5378.2000.00027.x. Helicobacter. 2000. PMID: 10971683 Clinical Trial.
In this study, we compared "absorbable" (colloidal bismuth subcitrate) and "nonabsorbable" (bismuth subnitrate) bismuth as part of triple therapy in the eradication of H. pylori. ...Group CBS + Ab (n = 35) received colloidal bismuth subcitrate (one tab …
In this study, we compared "absorbable" (colloidal bismuth subcitrate) and "nonabsorbable" (bismuth subnitrate) bismuth as par …
Systematic Review and Meta-Analysis: Bismuth Enhances the Efficacy for Eradication of Helicobacter pylori.
Reum Choe A, Tae CH, Choi M, Shim KN, Jung HK. Reum Choe A, et al. Helicobacter. 2024 Sep-Oct;29(5):e13141. doi: 10.1111/hel.13141. Helicobacter. 2024. PMID: 39385325
Bismuth regimens in the high clarithromycin resistance area tend to enhance the eradication rate (OR = 1.66, 95% CI, 1.34-2.05 in ITT; OR = 2.22, 95% CI, 1.67-2.95 in PP analyses). Bismuth potassium citrate and bismuth subcitrate were more effective drug forms in re …
Bismuth regimens in the high clarithromycin resistance area tend to enhance the eradication rate (OR = 1.66, 95% CI, 1.34-2.05 in ITT; OR = …
A pilot study evaluating high dose esomeprazole, bismuth subcitrate and amoxicillin for eradicating Helicobacter pylori infection in Iran.
Tirgar Fakheri S, Shokri-Afra H, Graham DY, Bari Z, Fakheri H. Tirgar Fakheri S, et al. Helicobacter. 2024 Jan-Feb;29(1):e13061. doi: 10.1111/hel.13061. Helicobacter. 2024. PMID: 38411303 Clinical Trial.
Both groups were treated for 14 days similarly with esomeprazole (40 mg, twice daily) and bismuth subcitrate (240 mg, three times daily), but the dose of amoxicillin was varied between Groups A (750 mg) and B (1000 mg) three times daily. ...
Both groups were treated for 14 days similarly with esomeprazole (40 mg, twice daily) and bismuth subcitrate (240 mg, three ti …
Dosage of colloidal bismuth subcitrate in duodenal ulcer healing and clearance of Campylobacter pylori.
Coghlan J, Hutchinson L, Gilligan D, McKenna D, Keane C, Sweeney E, O'Morain C. Coghlan J, et al. Aliment Pharmacol Ther. 1990 Feb;4(1):49-54. doi: 10.1111/j.1365-2036.1990.tb00448.x. Aliment Pharmacol Ther. 1990. PMID: 2104073 Clinical Trial.
Sixty consecutive patients with endoscopically proven duodenal ulcers were given colloidal bismuth subcitrate tablets either as 120 mg q.d.s. or 240 mg b.d., in a randomized single-blind study. ...
Sixty consecutive patients with endoscopically proven duodenal ulcers were given colloidal bismuth subcitrate tablets either a …
Helicobacter pylori eradication with doxycycline-metronidazole-bismuth subcitrate triple therapy.
Borody TJ, George LL, Brandl S, Andrews P, Lenne J, Moore-Jones D, Devine M, Walton M. Borody TJ, et al. Scand J Gastroenterol. 1992 Apr;27(4):281-4. doi: 10.3109/00365529209000075. Scand J Gastroenterol. 1992. PMID: 1589705 Clinical Trial.
In this study patients with duodenal ulcer or non-ulcer dyspepsia positive for H. pylori were randomized to either doxycycline or tetracycline HCl triple therapy in conjunction with bismuth subcitrate and metronidazole. Of the 34 patients taking doxycycline, only 22 …
In this study patients with duodenal ulcer or non-ulcer dyspepsia positive for H. pylori were randomized to either doxycycline or tetracycli …
301 results